Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Identification of the human cytochrome P450 enzymes involved in the two oxidative steps in the bioactivation of clopidogrel to its pharmacologically active metabolite.

Kazui M, Nishiya Y, Ishizuka T, Hagihara K, Farid NA, Okazaki O, Ikeda T, Kurihara A.

Drug Metab Dispos. 2010 Jan;38(1):92-9. doi: 10.1124/dmd.109.029132.

PMID:
19812348
2.

Recent advances in the pharmacogenetics of clopidogrel.

Cuisset T, Morange PE, Alessi MC.

Hum Genet. 2012 May;131(5):653-64. doi: 10.1007/s00439-011-1130-6. Epub 2011 Dec 30. Review.

PMID:
22207144
3.

Genetic causes of clopidogrel nonresponsiveness: which ones really count?

Momary KM, Dorsch MP, Bates ER.

Pharmacotherapy. 2010 Mar;30(3):265-74. doi: 10.1592/phco.30.3.265. Review.

PMID:
20180610
4.

Proton pump inhibitors and clopidogrel.

Gaglia MA Jr, Waksman R.

Cardiovasc Ther. 2010 Jun;28(3):169-76. doi: 10.1111/j.1755-5922.2010.00143.x. Epub 2010 Mar 25. Review.

PMID:
20345494
5.

Clopidogrel resistance: pharmacokinetic or pharmacogenetic?

Ford NF.

J Clin Pharmacol. 2009 May;49(5):506-12. doi: 10.1177/0091270009332433. Epub 2009 Feb 26. Review.

PMID:
19246723
6.

[A current problem for regulators. Clopidogrel and pharmacokinetics].

Zündorf I, Dingermann T.

Pharm Unserer Zeit. 2009;38(4):360-7. doi: 10.1002/pauz.200900326. Review. German. No abstract available.

PMID:
19572363
7.

Factors associated with clopidogrel nonresponsiveness.

Momary KM, Dorsch MP.

Future Cardiol. 2010 Mar;6(2):195-210. doi: 10.2217/fca.10.1. Review.

PMID:
20230261
8.

Genetic determinants of platelet response to clopidogrel.

Kubica A, Kozinski M, Grzesk G, Fabiszak T, Navarese EP, Goch A.

J Thromb Thrombolysis. 2011 Nov;32(4):459-66. doi: 10.1007/s11239-011-0611-8. Review.

PMID:
21706290
9.

Pharmacogenomics of tamoxifen therapy.

Brauch H, Mürdter TE, Eichelbaum M, Schwab M.

Clin Chem. 2009 Oct;55(10):1770-82. doi: 10.1373/clinchem.2008.121756. Epub 2009 Jul 2. Review.

PMID:
19574470
10.

[Polymorphism and the level of P450 gene expression in xenobiotic metabolism].

Niemira M, Wiśniewska A, Mazerska Z.

Postepy Biochem. 2009;55(3):279-89. Review. Polish.

PMID:
19928584
11.

The clopidogrel-statin interaction.

Tantry US, Jeong YH, Gurbel PA.

Circ J. 2014;78(3):592-4. Epub 2014 Feb 7. Review. No abstract available.

PMID:
24521731
12.

Metabolic activation of clopidogrel: in vitro data provide conflicting evidence for the contributions of CYP2C19 and PON1.

Polasek TM, Doogue MP, Miners JO.

Ther Adv Drug Saf. 2011 Dec;2(6):253-61. doi: 10.1177/2042098611422559. Review.

PMID:
25083217
13.

Anti-Parkinson's disease drugs and pharmacogenetic considerations.

Agúndez JA, García-Martín E, Alonso-Navarro H, Jiménez-Jiménez FJ.

Expert Opin Drug Metab Toxicol. 2013 Jul;9(7):859-74. doi: 10.1517/17425255.2013.789018. Epub 2013 Apr 9. Review.

PMID:
23565891
14.

Clopidogrel and warfarin pharmacogenetic tests: what is the evidence for use in clinical practice?

Shahin MH, Johnson JA.

Curr Opin Cardiol. 2013 May;28(3):305-14. doi: 10.1097/HCO.0b013e32835f0bbc. Review.

PMID:
23478884
15.

Recent advances: the cytochrome P450 enzymes.

Slaughter RL, Edwards DJ.

Ann Pharmacother. 1995 Jun;29(6):619-24. Review.

PMID:
7663035
16.

ACCF/AHA Clopidogrel clinical alert: approaches to the FDA "boxed warning": a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the American Heart Association.

Society for Cardiovascular Angiography and Interventions.; Society of Thoracic Surgeons.; Writing Committee Members., Holmes DR Jr, Dehmer GJ, Kaul S, Leifer D, O'Gara PT, Stein CM.

Circulation. 2010 Aug 3;122(5):537-57. doi: 10.1161/CIR.0b013e3181ee08ed. Epub 2010 Jun 28. No abstract available.

PMID:
20585015
17.

Polymorphic drug metabolism in anaesthesia.

Restrepo JG, Garcia-Martín E, Martínez C, Agúndez JA.

Curr Drug Metab. 2009 Mar;10(3):236-46. Review.

PMID:
19442086
18.

Structure-function analysis of cytochromes P450 2B.

Zhao Y, Halpert JR.

Biochim Biophys Acta. 2007 Mar;1770(3):402-12. Epub 2006 Jul 22. Review.

PMID:
16935426
19.

Clobazam therapeutic drug monitoring: a comprehensive review of the literature with proposals to improve future studies.

de Leon J, Spina E, Diaz FJ.

Ther Drug Monit. 2013 Feb;35(1):30-47. doi: 10.1097/FTD.0b013e31827ada88. Review.

PMID:
23318278
20.

Molecular characterization of CYP2B6 substrates.

Ekins S, Iyer M, Krasowski MD, Kharasch ED.

Curr Drug Metab. 2008 Jun;9(5):363-73. Review.

PMID:
18537573

Supplemental Content

Support Center